FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282021874> ?p ?o ?g. }

• W4282021874 endingPage "i85" @default.
• W4282021874 startingPage "i85" @default.
• W4282021874 abstract "Abstract With a 2-year survival less than 20%, Diffuse Intrinsic Pontine Glioma (DIPG) is the principal cause of pediatric death. Despite recent advances in the current treatments, the outcome for children with DIPGs remains dismal. Since the approval of T-VEC for melanoma by the FDA, oncolytic adenoviruses have emerged as a promising therapeutic strategy for brain tumors. Thus, our group launched the first world clinical trial phase I with the oncolytic adenovirus Delta-24-RGD (DNX-2401 in the clinic) for newly diagnosed DIPG (NCT03178032), which has shown safety and feasibility. Despite DNX-2401 increases the recruitment of T cells into the tumor, they usually become inactive due to the non-responsive tumor microenvironment evidencing the urgent need to improve this strategy focusing on the generation of effective long-term immune responses. Therefore, we decided to combine the Delta-24-RGD with the targeting of the costimulatory molecule CD40 in immunocompetent mice bearing orthotopic DIPG. The activation of the CD40 receptor, which is expressed by antigen presenting cells (APC) such as microglia, macrophages, and dendritic cells, is known to increase antigen presentation and enable T-cell priming and activation. Here, we observed that in addition to Delta-24-RGD anti-tumor effects, the stimulation of CD40 (using an agonistic antibody) on the tumor APCs results in a remodeling of the tumor immune compartment towards a proinflammatory scenario and a more efficient T-cell infiltration. Of importance, the combination therapy extends survival of treated mice as compared to single treatments or non-treated mice. In addition, we observe a complete regression of tumors in more than 40% of treated mice and the development of long-term anti-tumor immunity. We believe that these results provide a translational breakthrough in the treatment of these lethal tumors and open the door for a future innovative clinical trial." @default.
• W4282021874 created "2022-06-13" @default.
• W4282021874 creator A5000183191 @default.
• W4282021874 creator A5003743953 @default.
• W4282021874 creator A5005329272 @default.
• W4282021874 creator A5024660935 @default.
• W4282021874 creator A5038432727 @default.
• W4282021874 creator A5043322499 @default.
• W4282021874 creator A5064785619 @default.
• W4282021874 creator A5067260013 @default.
• W4282021874 creator A5072773574 @default.
• W4282021874 creator A5077791294 @default.
• W4282021874 creator A5081301268 @default.
• W4282021874 creator A5089189433 @default.
• W4282021874 date "2022-06-01" @default.
• W4282021874 modified "2023-10-18" @default.
• W4282021874 title "IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas" @default.
• W4282021874 doi "https://doi.org/10.1093/neuonc/noac079.311" @default.
• W4282021874 hasPublicationYear "2022" @default.
• W4282021874 type Work @default.
• W4282021874 citedByCount "0" @default.
• W4282021874 crossrefType "journal-article" @default.
• W4282021874 hasAuthorship W4282021874A5000183191 @default.
• W4282021874 hasAuthorship W4282021874A5003743953 @default.
• W4282021874 hasAuthorship W4282021874A5005329272 @default.
• W4282021874 hasAuthorship W4282021874A5024660935 @default.
• W4282021874 hasAuthorship W4282021874A5038432727 @default.
• W4282021874 hasAuthorship W4282021874A5043322499 @default.
• W4282021874 hasAuthorship W4282021874A5064785619 @default.
• W4282021874 hasAuthorship W4282021874A5067260013 @default.
• W4282021874 hasAuthorship W4282021874A5072773574 @default.
• W4282021874 hasAuthorship W4282021874A5077791294 @default.
• W4282021874 hasAuthorship W4282021874A5081301268 @default.
• W4282021874 hasAuthorship W4282021874A5089189433 @default.
• W4282021874 hasBestOaLocation W42820218741 @default.
• W4282021874 hasConcept C147483822 @default.
• W4282021874 hasConcept C154317977 @default.
• W4282021874 hasConcept C202751555 @default.
• W4282021874 hasConcept C203014093 @default.
• W4282021874 hasConcept C2776090121 @default.
• W4282021874 hasConcept C2776107976 @default.
• W4282021874 hasConcept C2777283488 @default.
• W4282021874 hasConcept C2777701055 @default.
• W4282021874 hasConcept C2778227246 @default.
• W4282021874 hasConcept C39347974 @default.
• W4282021874 hasConcept C502942594 @default.
• W4282021874 hasConcept C55493867 @default.
• W4282021874 hasConcept C67662055 @default.
• W4282021874 hasConcept C71924100 @default.
• W4282021874 hasConcept C82210918 @default.
• W4282021874 hasConcept C83464605 @default.
• W4282021874 hasConcept C86803240 @default.
• W4282021874 hasConcept C8891405 @default.
• W4282021874 hasConceptScore W4282021874C147483822 @default.
• W4282021874 hasConceptScore W4282021874C154317977 @default.
• W4282021874 hasConceptScore W4282021874C202751555 @default.
• W4282021874 hasConceptScore W4282021874C203014093 @default.
• W4282021874 hasConceptScore W4282021874C2776090121 @default.
• W4282021874 hasConceptScore W4282021874C2776107976 @default.
• W4282021874 hasConceptScore W4282021874C2777283488 @default.
• W4282021874 hasConceptScore W4282021874C2777701055 @default.
• W4282021874 hasConceptScore W4282021874C2778227246 @default.
• W4282021874 hasConceptScore W4282021874C39347974 @default.
• W4282021874 hasConceptScore W4282021874C502942594 @default.
• W4282021874 hasConceptScore W4282021874C55493867 @default.
• W4282021874 hasConceptScore W4282021874C67662055 @default.
• W4282021874 hasConceptScore W4282021874C71924100 @default.
• W4282021874 hasConceptScore W4282021874C82210918 @default.
• W4282021874 hasConceptScore W4282021874C83464605 @default.
• W4282021874 hasConceptScore W4282021874C86803240 @default.
• W4282021874 hasConceptScore W4282021874C8891405 @default.
• W4282021874 hasIssue "Supplement_1" @default.
• W4282021874 hasLocation W42820218741 @default.
• W4282021874 hasLocation W42820218742 @default.
• W4282021874 hasOpenAccess W4282021874 @default.
• W4282021874 hasPrimaryLocation W42820218741 @default.
• W4282021874 hasRelatedWork W2077565043 @default.
• W4282021874 hasRelatedWork W2109415128 @default.
• W4282021874 hasRelatedWork W2139860153 @default.
• W4282021874 hasRelatedWork W2257930088 @default.
• W4282021874 hasRelatedWork W2406510374 @default.
• W4282021874 hasRelatedWork W2417011131 @default.
• W4282021874 hasRelatedWork W2995135350 @default.
• W4282021874 hasRelatedWork W3029072430 @default.
• W4282021874 hasRelatedWork W39915895 @default.
• W4282021874 hasRelatedWork W4385847677 @default.
• W4282021874 hasVolume "24" @default.
• W4282021874 isParatext "false" @default.
• W4282021874 isRetracted "false" @default.
• W4282021874 workType "article" @default.